Industry: Chemical & Material
Published Date: 2026-07-09
Pages: 127 Pages
Report ld: 6860174
Request Sample
Customized Report
Dihydromyricetin Market Size(US$)

CAGR 2026-2032
4.3%
Market Size,2032
USD 490
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Dihydromyricetin was estimated to be worth US$ 367 million in 2025 and is projected to reach US$ 490 million, growing at a CAGR of 4.3% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Dihydromyricetin cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Dihydromyricetin are extract from Vine Tea.In China, Vine Tea (DHM) is commonly known as Teng Cha and is sold/used as a herbal remedy to alleviate fevers, drunkness, cure rheumatism, strengthen physique, diuresis, and many other functions.
Plant extracts are substances or active substances with desired properties extracted from plant tissue and processed for a specific purpose. It is used in various fields, such as health foods, therapeutic drugs, cosmetics, processing aids, additives chemical substitutes. The market’s growth is driven by lifestyle changes, consumer awareness, increasing use of products based on natural ingredients, and biotechnology breakthroughs. Additionally, macroeconomic variables such as rising consumer disposable income, research and development, imports and exports, growth in the agriculture industry, population aging, and population growth have positively impacted the demand for plant extracts in recent years. It is also becoming increasingly popular in cosmetics, perfumes, pharmaceuticals, and dietary supplements. The plant extracts market was valued at USD 31.84 billion in 2022 and is expected to grow at a CAGR of 11.3% during the forecast period.
This report provides a comprehensive view of the global market for Dihydromyricetin, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Dihydromyricetin market size, estimations, and forecasts are presented in terms of sales volume (MT) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Dihydromyricetin.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Dihydromyricetin manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Dihydromyricetin sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Dihydromyricetin sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Dihydromyricetin Product Introduction
1.2 Global Dihydromyricetin Market Size Forecast
1.2.1 Global Dihydromyricetin Sales Value (2021–2032)
1.2.2 Global Dihydromyricetin Sales Volume (2021–2032)
1.2.3 Global Dihydromyricetin Sales Price (2021–2032)
1.3 Dihydromyricetin Market Trends & Drivers
1.3.1 Dihydromyricetin Industry Trends
1.3.2 Dihydromyricetin Market Drivers & Opportunities
1.3.3 Dihydromyricetin Market Challenges
1.3.4 Dihydromyricetin Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Dihydromyricetin Players Revenue Ranking (2025)
2.2 Global Dihydromyricetin Revenue by Company (2021–2026)
2.3 Global Dihydromyricetin Sales Volume Ranking of Players (2025)
2.4 Global Dihydromyricetin Sales Volume by Company (2021–2026)
2.5 Global Dihydromyricetin Average Price by Company (2021–2026)
2.6 Key Manufacturers Dihydromyricetin Manufacturing Base and Headquarters
2.7 Key Manufacturers Dihydromyricetin Product Offerings
2.8 Key Manufacturers Start of Mass Production of Dihydromyricetin
2.9 Dihydromyricetin Market Competitive Analysis
2.9.1 Dihydromyricetin Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Dihydromyricetin Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dihydromyricetin revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Dihydromyricetin Market Classification
3.1 Introduction by Type
3.1.1 0.95
3.1.2 0.98
3.1.3 Others
3.1.4 Global Dihydromyricetin Sales Value by Type
3.1.4.1 Global Dihydromyricetin Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Dihydromyricetin Sales Value, by Type (2021–2032)
3.1.4.3 Global Dihydromyricetin Sales Value, by Type (%), 2021–2032
3.1.5 Global Dihydromyricetin Sales Volume by Type
3.1.5.1 Global Dihydromyricetin Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Dihydromyricetin Sales Volume, by Type (2021–2032)
3.1.5.3 Global Dihydromyricetin Sales Volume, by Type (%), 2021–2032
3.1.6 Global Dihydromyricetin Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharma and Healthcare
4.1.2 Food and Feed Additives
4.1.3 Others
4.2 Global Dihydromyricetin Sales Value by Application
4.2.1 Global Dihydromyricetin Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Dihydromyricetin Sales Value, by Application (2021–2032)
4.2.3 Global Dihydromyricetin Sales Value, by Application (%), 2021–2032
4.3 Global Dihydromyricetin Sales Volume by Application
4.3.1 Global Dihydromyricetin Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Dihydromyricetin Sales Volume, by Application (2021–2032)
4.3.3 Global Dihydromyricetin Sales Volume, by Application (%), 2021–2032
4.4 Global Dihydromyricetin Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Dihydromyricetin Sales Value by Region
5.1.1 Global Dihydromyricetin Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Dihydromyricetin Sales Value by Region (2021–2026)
5.1.3 Global Dihydromyricetin Sales Value by Region (2027–2032)
5.1.4 Global Dihydromyricetin Sales Value by Region (%), 2021–2032
5.2 Global Dihydromyricetin Sales Volume by Region
5.2.1 Global Dihydromyricetin Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Dihydromyricetin Sales Volume by Region (2021–2026)
5.2.3 Global Dihydromyricetin Sales Volume by Region (2027–2032)
5.2.4 Global Dihydromyricetin Sales Volume by Region (%), 2021–2032
5.3 Global Dihydromyricetin Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Dihydromyricetin Sales Value, 2021–2032
5.4.2 North America Dihydromyricetin Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Dihydromyricetin Sales Value, 2021–2032
5.5.2 Europe Dihydromyricetin Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Dihydromyricetin Sales Value, 2021–2032
5.6.2 Asia Pacific Dihydromyricetin Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Dihydromyricetin Sales Value, 2021–2032
5.7.2 South America Dihydromyricetin Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Dihydromyricetin Sales Value, 2021–2032
5.8.2 Middle East & Africa Dihydromyricetin Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Dihydromyricetin Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Dihydromyricetin Sales Value and Sales Volume
6.2.1 Key Countries/Regions Dihydromyricetin Sales Value, 2021–2032
6.2.2 Key Countries/Regions Dihydromyricetin Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Dihydromyricetin Sales Value, 2021–2032
6.3.2 United States Dihydromyricetin Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Dihydromyricetin Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Dihydromyricetin Sales Value, 2021–2032
6.4.2 Europe Dihydromyricetin Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Dihydromyricetin Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Dihydromyricetin Sales Value, 2021–2032
6.5.2 China Dihydromyricetin Sales Value by Type (%), 2025 vs 2032
6.5.3 China Dihydromyricetin Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Dihydromyricetin Sales Value, 2021–2032
6.6.2 Japan Dihydromyricetin Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Dihydromyricetin Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Dihydromyricetin Sales Value, 2021–2032
6.7.2 South Korea Dihydromyricetin Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Dihydromyricetin Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Dihydromyricetin Sales Value, 2021–2032
6.8.2 Southeast Asia Dihydromyricetin Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Dihydromyricetin Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Dihydromyricetin Sales Value, 2021–2032
6.9.2 India Dihydromyricetin Sales Value by Type (%), 2025 vs 2032
6.9.3 India Dihydromyricetin Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Xian Sost Biotech
7.1.1 Xian Sost Biotech Company Information
7.1.2 Xian Sost Biotech Introduction and Business Overview
7.1.3 Xian Sost Biotech Dihydromyricetin Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Xian Sost Biotech Dihydromyricetin Product Offerings
7.1.5 Xian Sost Biotech Recent Developments
7.2 Wuhan Vanz Pharm
7.2.1 Wuhan Vanz Pharm Company Information
7.2.2 Wuhan Vanz Pharm Introduction and Business Overview
7.2.3 Wuhan Vanz Pharm Dihydromyricetin Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Wuhan Vanz Pharm Dihydromyricetin Product Offerings
7.2.5 Wuhan Vanz Pharm Recent Developments
7.3 Xi'an Lyphar Biotech
7.3.1 Xi'an Lyphar Biotech Company Information
7.3.2 Xi'an Lyphar Biotech Introduction and Business Overview
7.3.3 Xi'an Lyphar Biotech Dihydromyricetin Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Xi'an Lyphar Biotech Dihydromyricetin Product Offerings
7.3.5 Xi'an Lyphar Biotech Recent Developments
7.4 Xi'an Natural Field Bio-Technique
7.4.1 Xi'an Natural Field Bio-Technique Company Information
7.4.2 Xi'an Natural Field Bio-Technique Introduction and Business Overview
7.4.3 Xi'an Natural Field Bio-Technique Dihydromyricetin Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Xi'an Natural Field Bio-Technique Dihydromyricetin Product Offerings
7.4.5 Xi'an Natural Field Bio-Technique Recent Developments
7.5 Xian Tonking Biotech
7.5.1 Xian Tonking Biotech Company Information
7.5.2 Xian Tonking Biotech Introduction and Business Overview
7.5.3 Xian Tonking Biotech Dihydromyricetin Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Xian Tonking Biotech Dihydromyricetin Product Offerings
7.5.5 Xian Tonking Biotech Recent Developments
7.6 Yongzhou Huamao Biotechnology
7.6.1 Yongzhou Huamao Biotechnology Company Information
7.6.2 Yongzhou Huamao Biotechnology Introduction and Business Overview
7.6.3 Yongzhou Huamao Biotechnology Dihydromyricetin Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Yongzhou Huamao Biotechnology Dihydromyricetin Product Offerings
7.6.5 Yongzhou Huamao Biotechnology Recent Developments
7.7 Xi'an Arisun ChemPharm
7.7.1 Xi'an Arisun ChemPharm Company Information
7.7.2 Xi'an Arisun ChemPharm Introduction and Business Overview
7.7.3 Xi'an Arisun ChemPharm Dihydromyricetin Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Xi'an Arisun ChemPharm Dihydromyricetin Product Offerings
7.7.5 Xi'an Arisun ChemPharm Recent Developments
7.8 Xi'an Pincredit Bio-Tech
7.8.1 Xi'an Pincredit Bio-Tech Company Information
7.8.2 Xi'an Pincredit Bio-Tech Introduction and Business Overview
7.8.3 Xi'an Pincredit Bio-Tech Dihydromyricetin Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Xi'an Pincredit Bio-Tech Dihydromyricetin Product Offerings
7.8.5 Xi'an Pincredit Bio-Tech Recent Developments
7.9 Chengdu Push Bio-technology
7.9.1 Chengdu Push Bio-technology Company Information
7.9.2 Chengdu Push Bio-technology Introduction and Business Overview
7.9.3 Chengdu Push Bio-technology Dihydromyricetin Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Chengdu Push Bio-technology Dihydromyricetin Product Offerings
7.9.5 Chengdu Push Bio-technology Recent Developments
8 Industry Chain Analysis
8.1 Dihydromyricetin Industrial Chain
8.2 Dihydromyricetin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Dihydromyricetin Sales Model
8.5.2 Sales Channels
8.5.3 Dihydromyricetin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Dihydromyricetin market was valued at US$ 367 million in 2025 and is anticipated to reach US$ 490 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-04-25
Pages: 134
USD 2900.00
(Single User License)
The global Dihydromyricetin market is projected to grow from US$ 353 million in 2024 to US$ 472 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 149
USD 4900.00
(Single User License)
The global Dihydromyricetin market size was US$ 353 million in 2024 and is forecast to a readjusted size of US$ 472 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 77
USD 4250.00
(Single User License)
The global market for Dihydromyricetin was valued at US$ 353 million in the year 2024 and is projected to reach a revised size of US$ 472 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-02-21
Pages: 93
USD 2900.00
(Single User License)
The global market for Dihydromyricetin was estimated to be worth US$ 353 million in 2024 and is forecast to a readjusted size of US$ 472 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 96
USD 3950.00
(Single User License)
Dihydromyricetin are extract from Vine Tea.In China, Vine Tea (DHM) is commonly known as Teng Cha and is sold/used as a herbal remedy to alleviate fevers, drunkness, cure rheumatism, strengthen physique, diuresis, and many other functions.
Published Date: 2024-04-07
Pages: 93
USD 4900.00
(Single User License)
Dihydromyricetin are extract from Vine Tea.In China, Vine Tea (DHM) is commonly known as Teng Cha and is sold/used as a herbal remedy to alleviate fevers, drunkness, cure rheumatism, strengthen physique, diuresis, and many other functions.
Published Date: 2024-01-10
Pages: 85
USD 2900.00
(Single User License)
The global Dihydromyricetin market was valued at US$ 367 million in 2025 and is anticipated to reach US$ 490 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-04-25
Pages: 134
The global Dihydromyricetin market is projected to grow from US$ 353 million in 2024 to US$ 472 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 149
The global Dihydromyricetin market size was US$ 353 million in 2024 and is forecast to a readjusted size of US$ 472 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 77
The global market for Dihydromyricetin was valued at US$ 353 million in the year 2024 and is projected to reach a revised size of US$ 472 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-02-21
Pages: 93
The global market for Dihydromyricetin was estimated to be worth US$ 353 million in 2024 and is forecast to a readjusted size of US$ 472 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 96
Dihydromyricetin are extract from Vine Tea.In China, Vine Tea (DHM) is commonly known as Teng Cha and is sold/used as a herbal remedy to alleviate fevers, drunkness, cure rheumatism, strengthen physique, diuresis, and many other functions.
Published: 2024-04-07
Pages: 93
Dihydromyricetin are extract from Vine Tea.In China, Vine Tea (DHM) is commonly known as Teng Cha and is sold/used as a herbal remedy to alleviate fevers, drunkness, cure rheumatism, strengthen physique, diuresis, and many other functions.
Published: 2024-01-10
Pages: 85
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now